Renal transplantation with cyclosporine in the elderly population.
Velez
R L
RL
Methodist Medical Center, Dallas, Texas.
Brinker
K R
KR
Vergne-Marini
P J
PJ
Nesser
D A
DA
Long
D L
DL
Trevino
G
G
Dickerman
R M
RM
Helfrich
G B
GB
D000328:Adult; D000367:Age Factors; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D003141:Communicable Diseases / Q000150:complications; D003524:Cyclosporins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3; D009369:Neoplasms / Q000150:complications; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D003524:Cyclosporins; D016853:Muromonab-CD3; D011241:Prednisone